Skip to main content
Commentary

Farewell to a cancer that never was.

Lyon J. Farewell to a Cancer That Never Was. JAMA. 2017;317(18):1824-1825. doi:10.1001/jama.2017.3969.

Save
Print
May 31, 2017
Lyon J. JAMA. 2017;317(18):1824-1825.

Overdiagnosis can result in financial, psychological, and physical harm for patients. This commentary discusses the reclassification of a subtype of thyroid cancer as a nonmalignancy and the impact changing guidelines can have on patients.

Save
Print
Cite
Citation

Lyon J. Farewell to a Cancer That Never Was. JAMA. 2017;317(18):1824-1825. doi:10.1001/jama.2017.3969.

Related Resources